Page 243 - Sigmaroc Annual-Report 2023

31. NON-CONTROLLING INTERESTS
Consolidated
243
31 December 2023 31 December 2022 £’000 £’000
11,732
10,894
616
974
3,184
2,343
(1,275)
(3,038)
(114)
559
14,143
11,732
As at 1 January
Acquired in business combination
Non-controlling interests share of profit in the period Dividends paid
Foreign exchange movement
As at 31 December
Current assets Non-current assets Current liabilities Non-current liabilities Net Assets
Net Assets Attributable to NCI
31 December 2023
14,459 23,612 (8,442) (6,082) 23,547
7,800
31 December 2022
12,427 19,605 (7,627) (4,361) 20,044
7,366
23,662 1,993 - 1,993 1,556 (2,782) 1,701 -
Suomen Karbonaatti £’000
2,489
4,192
38,252
Other individually immaterial subsidiaries £’000
18,762
(4,919)
(7,807)
8,525
4,108
-
4,108
4,486
(324)
(2,610)
1,275
Suomen Karbonaatti £’000
3,348
3,527
37,760
Other individually immaterial subsidiaries £’000
17,592
(7,975)
(5,767)
7,198
3,294
-
3,294
4,196
(679)
(6,208)
3,038
Revenue 32,062
Profit after taxation
Other comprehensive income Total comprehensive income Net operating cash flow
Net investing cash flow
Net financing cash flow Dividends paid to NCI
32. EARNINGS PER SHARE
The calculation of the total basic earnings per share of 1.98 pence (2022: 4.89 pence) is calculated by dividing the profit attributable to shareholders of £13,534 million (2022: £31,238 million) by the weighted average number of ordinary shares of 684,973,893 (2022: 638,243,627) in issue during the period.
Diluted earnings per share of 1.90 pence (2022: 4.68 pence) is calculated by dividing the profit attributable to
3,705 - 3,705 5,081 (8,971) 4,021 -
shareholders of £13,534 million (2022: £31,238 million) by the weighted average number of ordinary shares in issue during the period plus the weighted average number of share options and warrants to subscribe for ordinary shares in the Company, which together total 714,091,517 (2022: 667,430,527). The weighted average number of shares is the opening balance of ordinary shares plus the weighted average of 46,727,549 shares.
Details of share options that could potentially dilute earnings per share in future periods are disclosed in Note 29.